AR and posterior cortical atrophy: Prostate and EGFR-mutant lung adenocarcinoma initially respond to the first generation of antiandrogens (ADT), which inhibit the expression of AR signaling pathways, one of the principal drivers of PCa progression [160] and EGFR inhibitors, respectively.